Affective Touch, Hedonia and Suicidal Behavior
TOUCH-S
1 other identifier
interventional
72
1 country
1
Brief Summary
Several elements suggest that suicidal vulnerability may be associated with an alteration in the perception of affective touch. On the one hand, anhedonia, characterized by a decrease in the pleasure felt, is strongly associated with suicidal ideation, independently of depression. However, the ability to feel pleasure is essential in the perception of affective touch. On the other hand, suicidal behaviors are associated with interpersonal difficulties, of which communication is an integral part, and communication is partly through touch. The investigators therefore wish to explore the perception of affective touch in suicidal behavior by using an affective tactile stimulation in 72 subjects with and without a history of suicide attempts (SA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedStudy Start
First participant enrolled
February 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2024
CompletedJanuary 10, 2025
January 1, 2025
2.6 years
December 22, 2021
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pleasantness of the touch
Perceived pleasantness of the tactile stimulation, assessed with a numeric scale ranging from -5 (very unpleasant) to +5 (very pleasant)
at inclusion
Secondary Outcomes (5)
Intensity of the touch
at inclusion
Decision-making performance (Iowa Gambling Test)
at inclusion
Decision-making performance (Ultimatum Game)
at inclusion
β-endorphin levels
at inclusion
Variation in the expression of opioidergic genes
at inclusion
Study Arms (2)
Euthymic patients with history of suicide attempt (suicide attempters)
EXPERIMENTALCurrently euthymic patients with at least one lifetime major depressive episode and a history of suicide attempts
Euthymic patients without any history of suicide attempt (affective controls)
EXPERIMENTALCurrently euthymic patients with at least one lifetime major depressive episode and with no history of suicide attempts
Interventions
The experimental task aims to evaluate the hedonic nature of an affective touch by tactile stimulation. It consists in stimulating two adjacent regions of the left forearm, delimited and marked, of 9 cm x 4 cm each. In order to limit habituation, the stimulation areas will be alternated. To stimulate these areas, the investigator (previously trained) strokes the participant with a brush at an optimal speed to stimulate the C-fibers (3 cm/s; slow speed) or not (18 cm/s; fast speed). Touch will consist of 30 seconds blocks of stimulation, performed on one of the two identified areas, from the elbow to the wrist. In total, 6 stimulation blocks will be done (3 slow and 3 fast), the order and location of which will be random in order to limit habituation. This stimulation is completely painless. After each block, the participant will evaluate the intensity of the stimulation and its pleasantness.
Eligibility Criteria
You may qualify if:
- Being a woman
- Aged between 18 and 65
- Past major depressive episode according to the DSM-5 criteria
- Currently euthymic (Montgomery-Asberg Depression rating Scale (MADRS) \< 12 and Young Mania Rating Scale (YMRS) \< 6)
- Minimal psychotropic medication (as determined by the clinician)
- Able to understand experimental procedures
- Able to speak, read and understand French
- Having given written informed consent
- For suicide attempters only: Lifetime history of suicide attempt
- For affective controls only: No lifetime history of suicide attempt
You may not qualify if:
- Lifetime diagnosis of schizoaffective disorder, schizophrenia or autism spectrum disorder
- Severe alcohol or substance use disorder in the past 6 months
- Current anorexia nervosa
- Diagnosis of mental retardation or severe medical comorbidity that is unstable or could interfere with measures (HIV, diabetes, cancer, chronic inflammatory disease, neurological disorder, sensory or cognitive disability)
- Injury, scar, irritation/dermatological lesion or tattoo on the left forearm
- Pregnancy or breastfeeding
- Not being affiliated to the French National Social Security System
- Being deprived of freedom (by judicial or administrative decision)
- Being protected by law (guardianship or curatorship)
- Having reached 4500€ annual compensation for participating to clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montpellier University Hospital, France (CHU)
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
January 10, 2022
Study Start
February 11, 2022
Primary Completion
September 9, 2024
Study Completion
September 9, 2024
Last Updated
January 10, 2025
Record last verified: 2025-01